Targeting HIV reservoirs and reconstituting the immune system. Second annual meeting Research Institute for Genetic and Human Therapy April 18-19, 1999 Washington, DC.
Lori
F
F
Lisziewicz
J
J
D016915:AIDS Vaccines / Q000276:immunology; D000328:Adult; D000818:Animals; D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D015331:Cohort Studies; D003588:Cytopathogenic Effect, Viral; D003713:Dendritic Cells / Q000276:immunology / Q000637:transplantation / Q000821:virology; D004197:Disease Reservoirs; D004352:Drug Resistance, Microbial; D004359:Drug Therapy, Combination; D005260:Female; D015316:Genetic Therapy; D005822:Genetic Vectors / Q000235:genetics / Q000627:therapeutic use; D015658:HIV Infections / Q000276:immunology* / Q000517:prevention & control / Q000628:therapy; D017320:HIV Protease Inhibitors / Q000627:therapeutic use; D015497:HIV-1 / Q000187:drug effects / Q000235:genetics / Q000276:immunology / Q000502:physiology; D018380:Hematopoietic Stem Cell Transplantation; D006412:Hematopoietic Stem Cells / Q000378:metabolism; D006801:Humans; D006918:Hydroxyurea / Q000008:administration & dosage / Q000627:therapeutic use; D007111:Immunity, Cellular; D007116:Immunization, Passive; D016219:Immunotherapy, Adoptive; D016131:Lymphocyte Subsets / Q000276:immunology / Q000821:virology; D008252:Macaca fascicularis; D008297:Male; D011323:Primates / Q000821:virology; D011446:Prospective Studies; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use; D016879:Salvage Therapy; D016097:Simian Acquired Immunodeficiency Syndrome / Q000276:immunology / Q000821:virology; D015302:Simian Immunodeficiency Virus / Q000502:physiology; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology; D019444:Vaccines, DNA / Q000276:immunology
D016915:AIDS Vaccines; D019380:Anti-HIV Agents; D017320:HIV Protease Inhibitors; D018894:Reverse Transcriptase Inhibitors; D019444:Vaccines, DNA; D006918:Hydroxyurea